Nova Eye Medical 2023 Glaucoma AMD Investor Presentation

Nova Eye Medical presents its strategic initiatives to address glaucoma and age-related macular degeneration (AMD), the leading causes of blindness. The company details its canaloplasty surgical devices portfolio, 2RT technology for intermediate AMD, established US and international sales infrastructure, and regulatory clearances across major markets including FDA approval.